(S (NP-SBJ-55 (NP-COOD (NP (NP Susceptibility/NN) (PP to/TO (NP natural/JJ killer/NN cells/NNS))) and/CC (NP (NP down/JJ regulation/NN) (PP of/IN (NP MHC/NN class/NN I/CD expression/NN)))) (PP in/IN (NP adenovirus/NN 12/CD transformed/VBN cells/NNS))) (VP are/VBP (VP regulated/VBN (NP *-55/-NONE-) (PP by/IN (NP-LGS different/JJ E1A/NN domains/NNS)))) ./.)
(S (S-COOD (S (NP-SBJ All/DT human/JJ adenoviruses/NNS) (VP transform/VBP (NP rodent/JJ cells/NNS) (ADVP in/FW vitro/FW))) ,/, but/CC (S (NP-SBJ (NP only/RB cells/NNS) (VP transformed/VBN (NP */-NONE-) (PP by/IN (NP-LGS (NP serotypes/NNS) (VP belonging/VBG (PP to/TO (NP subgroups/NNS (NP-COOD (NP (NP A/NN) (PRN -LRB-/-LRB- (NP Ad12/NN) -RRB-/-RRB-)) and/CC (NP (NP B/NN) (PRN -LRB-/-LRB- (NP Ad3/NN) -RRB-/-RRB-)))))))))) (VP are/VBP (ADJP-PRD tumorigenic/JJ) (PP for/IN (NP immunocompetent/JJ animals/NNS))))) ./.)
(S (PP In/IN (NP these/DT cells/NNS)) ,/, (NP-SBJ-56 (NP the/DT expression/NN) (PP of/IN (NP MHC-class/NN I/CD antigens/NNS))) (VP-COOD (VP is/VBZ (VP repressed/VBN (NP *-56/-NONE-))) and/CC (VP might/MD (VP allow/VB (S (NP-SBJ them/PRP) (VP-COOD (VP to/TO (VP escape/VB (PP from/IN (NP (NP recognition/NN) (PP by/IN (NP (NP cytotoxic/JJ T/NN lymphocytes/NNS) (PRN -LRB-/-LRB- (NP CTL/NN) -RRB-/-RRB-))))))) and/CC (VP to/TO (VP develop/VB (PP in/IN (NP tumor/NN))))))))) ./.)
(S (ADVP Furthermore/RB) ,/, (NP-SBJ these/DT cell/NN lines/NNS) (VP appear/VBP (ADJP-PRD resistant/JJ (PP to/TO (NP (NP lysis/NN) (PP by/IN (NP (NP (NP natural/JJ killer/NN) (PRN -LRB-/-LRB- (NP NK/NN) -RRB-/-RRB-)) cells/NNS)))))) ./.)
(S (S (NP-SBJ */-NONE-) (VP To/TO (VP determine/VB (NP (NP the/DT E1A/NN domain/NN -LRB-/-LRB- s/NNS -RRB-/-RRB-) (ADJP responsible/JJ (PP for/IN (NP these/DT properties/NNS))))))) (NP-SBJ-57 several/JJ cell/NN lines/NNS) (VP were/VBD (VP created/VBN (NP *-57/-NONE-) (PP by/IN (S (NP-SBJ */-NONE-) (NP transforming/VBG (NP (NP (NP baby/NN rat/NN kidney/NN) (PRN -LRB-/-LRB- (NP BRK/NN) -RRB-/-RRB-)) cells/NNS) (PP with/IN (NP (NP a/DT set/NN) (PP of/IN (NP (NP plasmids/NNS) (VP expressing/VBG (NP different/JJ Ad2\/Ad12/NN hybrid/NN E1A/NN gene/NN products/NNS))))))))))) ./.)
(S (NP-SBJ-58 The/DT MHC/NN class/NN 1/CD gene/NN expression/NN) (VP was/VBD (VP inhibited/VBN (NP *-58/-NONE-) (PP-COOD (PP in/IN (NP (NP cells/NNS) (VP expressing/VBG (NP the/DT Ad12/NN 13S/NN mRNA/NN product/NN)))) and/CC (PP in/IN (NP (NP cells/NNS) (VP transformed/VBN (NP */-NONE-) (PP with/IN (NP (NP Ad2\/Ad12/NN hybrid/NN E1A/NN gene/NN product/NN) (VP harboring/VBG (NP (NP the/DT C-terminal/JJ part/NN) (PP of/IN (NP (NP the/DT (NP (NP conserved/VBN region/NN) (PRN -LRB-/-LRB- (NP CR/NN) -RRB-/-RRB-)) 3/CD) (PP of/IN (NP Ad12/NN)))))))))))))) ./.)
(S (NP-SBJ-59 (NP Susceptibility/NN) (PP of/IN (NP these/DT transformed/VBN cell/NN lines/NNS)) (PP to/TO (NP NK/NN cells/NNS))) (VP was/VBD (VP determined/VBN (NP *-59/-NONE-) (PP by/IN (NP-LGS cytolytic/JJ assays/NNS)))) ./.)
(S (NP-SBJ (NP The/DT results/NNS) (VP obtained/VBD (NP */-NONE-))) (VP suggest/VBP (SBAR that/IN (S (NP-SBJ-60 two/CD Ad12/NN E1A/NN domains/NNS) (VP are/VBP (VP required/VBN (NP *-60/-NONE-) (S (NP-SBJ */-NONE-) (VP to/TO (VP induce/VB (NP (NP resistance/NN) (PP of/IN (NP the/DT cell/NN lines/NNS)) (PP to/TO (NP NK/NN cells/NNS))))))))))) ./.)
